Sam K Engrav

Papers

Total Citations

H-Index

About

Sam K Engrav is a surgical oncologist whose research focuses on optimizing surgical outcomes for early-stage lung cancer, particularly through the integration of intraoperative pathology. His most-cited work, "Impact of Frozen Section Pathology Examination of Surgical Margins in Sublobar Pulmonary Resections for Clinical Stage IA Non-small Cell Lung Cancer" (2025, 3 citations), addresses a critical clinical question: whether real-time margin assessment during sublobar resections can reduce recurrence rates and improve patient prognosis. This study contributes to the growing body of evidence supporting precision surgery for stage IA non-small cell lung cancer, where the balance between preserving lung function and achieving complete tumor removal is paramount. Engrav’s research underscores the importance of multidisciplinary collaboration between surgeons and pathologists in the operating room. While his citation count is still emerging, his work is positioned to influence surgical guidelines and practice patterns in thoracic oncology. Engrav’s dedication to refining surgical techniques and improving patient outcomes marks him as a promising voice in the field of lung cancer surgery.